Key Words: plakophilin-2 Ⅲ intercalated disc Ⅲ arrhythmogenic right ventricular cardiomyopathy Ⅲ cardiac desmosomes A high-resolution image of the site of end-end contact between cardiomyocytes reveals an electron-dense organization called "the intercalated disc." Its classic definition involves 3 structures: desmosomes and adherens junctions, providing mechanical coupling; and gap junctions, allowing electric/metabolic synchronization between cells. Recent studies show that other molecules, not directly involved in intercellular coupling, also reside preferentially at the intercalated disc. Among them is Na V 1.5, the major ␣ subunit of the cardiac sodium channel. 1 Here, we ask whether Na v 1.5 and the desmosomal protein plakophilin-2 (PKP2) coexist in the same molecular complex and whether loss of PKP2 expression affects (1) the amplitude and kinetics of the sodium current and (2) action potential propagation in a monolayer of cardiomyocytes. Our data demonstrate a functional crosstalk between a protein defined in the context of intercellular junctions (PKP2) and another protein that is fundamental to the electrical behavior of the single myocyte.
A high-resolution image of the site of end-end contact between cardiomyocytes reveals an electron-dense organization called "the intercalated disc." Its classic definition involves 3 structures: desmosomes and adherens junctions, providing mechanical coupling; and gap junctions, allowing electric/metabolic synchronization between cells. Recent studies show that other molecules, not directly involved in intercellular coupling, also reside preferentially at the intercalated disc. Among them is Na V 1.5, the major ␣ subunit of the cardiac sodium channel. 1 Here, we ask whether Na v 1.5 and the desmosomal protein plakophilin-2 (PKP2) coexist in the same molecular complex and whether loss of PKP2 expression affects (1) the amplitude and kinetics of the sodium current and (2) action potential propagation in a monolayer of cardiomyocytes. Our data demonstrate a functional crosstalk between a protein defined in the context of intercellular junctions (PKP2) and another protein that is fundamental to the electrical behavior of the single myocyte.
Methods
An expanded Methods section is available in the Online Data Supplement at http://circres.ahajournals.org.
Results and Discussion
Initial experiments aimed at whether Na v 1.5 and PKP2 are present in the same molecular complex. A recombinant protein formed by glutathione S-transferase (GST) concatenated to the head domain of PKP2 (GST-PKP2-H) was bound to glutathione-Sepharose beads, and presented to an adult heart lysate. The precipitate was immunoblotted for Na v 1.5 ( Figure 1A ). GST, bound to beads but not PKP2-concatenated, was used as control (first 2 lanes). PKP2-H pulled down Na v 1.5 from heart lysate, suggesting a physical interaction, direct or indirect, between the 2 proteins. Interaction between Na v 1.5 and native PKP2 was tested by coimmunoprecipitation. Na v 1.5 was precipitated by antibodycoated beads ( Figure 1B, top) . Western blots demonstrated PKP2 in the precipitate (bottom). Immunofluorescence studies in freshly dissociated myocytes showed colocalization of Na V 1.5 with PKP2 at the site originally occupied by the intercalated disc ( Figure 1C and 1E ). This subcellular distribution shifted with time in culture. After 6 days (time frame required for silencing experiments; see below), the density of immunoreactive signal at the cell ends decreased, coincident with the appearance of punctate immunoreactive spots on the lateral membranes, better resolved for PKP2 staining ( Figure 1D and 1F). Na v 1.5 staining was less sharply defined, making it difficult to establish the extent of colocalization, though a coincidence of signals could be found ( Figure 1F ). Protein relocalization did not affect the kinetics of I Na (Online Figure   I ). Next, we assessed the properties of I Na as a function of PKP2 expression.
PKP2 level was decreased (Ͻ80% from control) by use of short hairpin (sh)RNA. In a first group, a mixture of 4 separate oligonucleotides, designed for selective PKP2 mRNA knockdown (KD) was introduced into myocytes using a transfection reagent (Dharmafect-1). Alternative nontargeted siRNA was used as control (⌽KD; details online). For every experiment, PKP2 silencing was confirmed by immunoblot (Online Figure II) . Sodium currents were recorded by voltage clamp (Online Data Supplement). Figure 2A shows an example of currents obtained from cells either untreated (UNT) or treated with an oligonucleotide mixture. Composite data are displayed in Figure 2B through 2D. Treatment with control ⌽KD constructs did not affect current parameters. However, a decrease in peak current density (2B), a shift in voltage dependence of steady-state inactivation (2C), and a prolongation of time-dependence of recovery from inactivation (2D) were observed in PKP2-silenced cells.
To reduce the possibility of off-target effects, additional experiments were conducted where a single silencing construct, of different sequence than those in the KD mixture and yet selective for PKP2, was transferred into myocytes via adenoviral infection (shRNA). Results were compared with those obtained from cells untreated (UNT), or treated with a nonsilencing construct (⌽shRNA 2 ). These results (Online Figures III and IV) , consistently demonstrated that loss of PKP2 expression associated with reduced peak current density, negatively shifted voltage dependence of inactivation, and prolonged recovery from inactivation of sodium currents. Overall, we show that loss of PKP2 expression affects sodium current properties, regardless of the experimental procedure to achieve PKP2 knockdown. Previously, we demonstrated that loss of PKP2 expression in neonatal rat ventricular myocytes causes connexin (Cx)43 remodeling 2 and an Ϸ60% decrease in cell-cell dye coupling. 2 We predicted that, combined with the change in sodium current function reported here, loss of PKP2 expression would significantly affect propagation properties in cardiomyocytes. Optical mapping experiments in monolayers of neonatal rat ventricular myocytes revealed that loss of PKP2 expression caused slowing of action potential propagation, rate-dependent activation failure, and arrhythmic behavior. Results are shown in Figure 3 . Cells were treated with adenovirus containing either the ⌽shRNA or the PKP2-shRNA constructs. We chose this method of silencing for consistency with our previous studies. 2 Cells were paced at constant frequency from a stimulating electrode in the center of the dish. Only quiescent preparations were used for the study. Care was taken to minimize the presence of fibroblasts. Average conduction velocity in control monolayers paced at 1 Hz was 24.55 cm/sec (nϭ9). Examples of isochrone maps from preparations treated with either ⌽shRNA or PKP2-shRNA are shown in Figure 3A Figure IV) , we observed an increase in average conduction velocity in monolayers treated with ⌽shRNA virus. In contrast, we observed a large decrease in conduction velocity in preparations treated with PKP2-shRNA. In addition, a 1:1 stimulus:response capture at pacing frequencies higher than 8 Hz was possible in a fraction of preparations either untreated, or treated with ⌽shRNA, whereas we failed to obtain 1:1 capture in all PKP2 knockdown monolayers. Instead, we observed nonpaced sustained reentrant activity within the preparation (see phase map in Figure 3D ). This is the first report demonstrating a link between loss of PKP2 expression, impaired cardiac propagation, and loss of electric synchrony.
The relative contributions of decreased junctional conductance versus sodium current on the observed changes in conduction velocity remain undefined. Cable equations predict a decrease in conduction velocity for an increase in axial resistivity. 3 Yet, studies in genetically modified animals indicate that a 50% decrease in Cx43 content, and a concurrent decrease in electrical coupling, are not enough to significantly decrease conduction velocity, perhaps because of the relatively large contribution of myoplasmic resistivity to the total internal resistance (see Beauchamp et al 4 and references within). Likely, the observed decrease in conduction velocity resulting from loss of PKP2 expression is consequent to both decreased electrical coupling 2 and decreased sodium current, although dissecting the relative contributions will require further experimentation. In addition, our present results do not discard a possible effect of PKP2 silencing 
on membrane potential; membrane depolarization could be another factor, leading to slow conduction velocity in these preparations. Future experiments will be necessary to address this possibility.
Our data suggest a link between three components of the intercalated disc: desmosomes, gap junctions, and the voltage-gated sodium channel Na v 1.5 complex. Crosstalk between PKP2 and Cx43 and coprecipitation of Cx43 and Na v 1.5 have been demonstrated. 2, 5 Yet, this is the first evidence of association between PKP2 expression and function of the sodium channel complex and the first demonstration that molecular integrity of mechanical junctions can be relevant to ion channel function. We further demonstrate that loss of PKP2 expression leads to slow conduction velocity and propensity for frequency-dependent arrhythmias. The mechanisms by which this triad (desmosomes, gap junctions, sodium channels) is linked remain unknown. We emphasize that, because of the time required for PKP2 silencing, patch-clamp experiments were carried out within a time frame that overlaps with intercalated disc remodeling. 6 As such, the PKP2-Na v 1.5 interaction did not occur within the confines of the intercalated disc. Yet, it was only after PKP2 knockdown that the change in I Na properties became apparent. The latter indicates that during intercalated disc remodeling, PKP2 retains a physical interaction, direct or indirect, with Na v 1.5, which carries a functional effect. We speculate that PKP2 may be important in the association of Na v 1.5 with its noncovalently linked ␤ subunit(s), and/or the cytoskeletal adaptor protein, ankyrin-G; alternatively (or in addition), a direct PKP2-Na v 1.5 association with impact on the biophysical properties of the channel cannot be discarded. Furthermore, whether these interactions occur in the heart in vivo, and/or in the confines of the intercalated disc of an intact heart, remains to be demonstrated. Of relevance, mutations in PKP2 are linked to arrhythmogenic right ventricular cardiomyopathy, an inherited disease associated with ventricular arrhythmias and sudden death in the young. The mechanisms by which mutations in mechanical junction proteins affect electric synchrony remain undefined. Whether the results presented here, in an in vitro system, bear relevance to the pathogenesis of arrhythmogenic right ventricular cardiomyopathy is a tantalizing hypothesis for future investigation.
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Supplement Material Preparation of recombinant GST-fusion proteins
Recombinant GST fusion proteins were generated in BL-21 E. Coli. Production of a protein fragment corresponding to the head domain of PKP2 (GST-PKP2H; amino acids 1-335 of PKP2a) followed the methods described elsewhere. 1 Briefly, crude lysates were prepared by sonication of one liter bacterial pellets in 20 ml of PBS protein purification buffer containing (in mM): NaCl, 138; KH 2 PO 4 , 1.5; Na 2 HPO 4 , 8; KCl, 2.7 (pH 7.4); DTT, 1.0; PMSF, 1.0 as well as NP-40 (1%), followed by centrifugation at 12,000 rpm for 25 minutes. A total of 200 µl of crude bacterial lysate was mixed with 50 µl of Glutathione Sepharose 4B (GE Healthcare) in 1 ml of lysis buffer overnight at 4° C. Unbound proteins were removed by washing three times with heart lysis buffer (in mM): Tris-HCl, 50; NaCl, 50; MgCl 2 , 2.0; EDTA, 2.0; NaF, 50; NaVO 3 , 1.0; as well as 1% bmercaptoethanol, 1% TritonX-100, and 1X Complete protease inhibitor (Roche Diagnostics). The solution was buffered to pH 7.4.
GST pulldown assay
Fresh rat heart lysates were prepared by homogenizing tissue on ice in TE solution (50mM Tris-HCl pH 7.4, 10mM EGTA with 1X Complete Protease inhibitors from Roche Diagnostics). The crude heart lysate was centrifuged at 3,500 rpm for 10 minutes. The remaining pellet was resuspended with TE, homogenized and centrifuged again as above. The supernatants were pooled and centrifuged at 40,000g for 30 minutes at 4° C. The pellet was resuspended with a lysis buffer containing 150mM NaCl, 50mM TrisHCl pH 7.4, 1mM EDTA, 1% TritonX-100, 0.2mM DTT, 1mM PMSF, 50mM NaF, 1mM NaVO 3 and 1X Complete Protease Inhibitor. One ml of supernatant was exposed to 250 µl of glutathione sepharose beads for 30 minutes at 4° C. After centrifugation at 2,500 rpm for 5 minutes, approximately 15 mg precleared heart lysate (+) was incubated with bound GST fusion proteins in 1 ml of lysis buffer for 90 minutes, rocking at 4° C. A separate sample was incubated with lysis buffer only (-) as a control. Unbound proteins were removed by washing 2 times with lysis buffer. The final pellet was resuspended in Laemmli sample buffer, heated at 37° C for 10 minutes and probed by standard western blot protocol. The same samples were run on a separate gel and stained (Coomassie) to assess total protein content.
Co-immunoprecipitation assay
Fresh rat heart lysates were prepared by homogenizing tissue on ice in a lysis buffer containing 50mM NaCl, 20mM Hepes, 1% TritonX-100, 0.5% NP-40, 1mM EDTA, 1mM PMSF, 1mM NaVO 3 , 50mM NaF and 1X Complete Protease Inhibitor. The crude heart lysate was centrifuged at 3,500 rpm for 15 minutes. To preclear the lysate, one ml of supernatant was exposed to 30 µl of Protein A/G Agarose beads (Santa Cruz Biotechnology) for 30 minutes at 4° C. After centrifugation at 3500 for 5 minutes, a protein concentration assay (Biorad) was performed. Immunoprecipitations were carried out in a volume of 1ml for 400 µg of total protein. A total of 15 µg of rabbit anti-NaV1.5 (Sigma #S0819) were added to the precleared lysates and the samples were incubated for 1 hour, rocking gently at 4° C. A total of 25 µl of protein A/G agarose beads were added, and the samples were incubated on a rocker for 1hour at 4° C. The antibodyprotein A/G agarose complex was spun down at 2500 rpm for 5 minutes and washed with lysis buffer three times. After the final spin, 100ul of lysis buffer and 20 µl of 6X Online Figure I . Sodium current parameters recorded from adult rat ventricular myocytes recorded within 24 hours (D1; black diamonds; n=5) or six days (D6; black circles; n=5) after dissociation. Data labeled "ФKD" (red; n=6) were collected six days after dissociation, and five days after the cells were transfected with the non-targeted siRNA that was used as a control (see also Figure 2 An increase in peak current amplitude was detected in cells treated with the non-silencing virus, perhaps suggesting an effect consequent to the interaction of the virus with its receptor in the myocyte (see, e.g., ref 6 ). It is interesting to note that the adenovirus receptor preferentially localizes to the intercalated disc. 6 Whether binding of the virus to its receptor brings about functional changes in I Na , remains to be determined. However, it is important to emphasize that the change in I Na caused by exposure to the virus is in the opposite direction to that observed after silencing and as such, it does not obscure the effect of the loss of PKP2 expression. More importantly, the amplitude of the peak voltage-gated sodium current in cells treated with the PKP2 silencing construct was significantly decreased when compared to control (p< 0.001). This result associated with a shift of the voltage dependence of steady-state inactivation toward the more negative values (panel C), as well as a prolongation of the time dependence of recovery from inactivation, from 5.03/20.9 ms (t1/t2) in untreated, and 2.91/13.03 ms (t1/t2) in ФshRNA-treated cells, to 24.2 ms (t1; best fit by a single exponential) in those cells where PKP2 expression was knocked down (panel D). The changes in the sodium current resulting from loss of PKP2 expression were consistent with those observed when PKP2 was reduced using non-viral technology and different oligonucleotide sequences ( Figure 2 Online Figure V 
